“…In this study, the utility of miR-10b, miR-21, miR-93, miR-107, miR-143, and miR-145 as novel diagnostic and prognostic biomarkers of GC was evaluated. Based on previous results and consistently with other studies, statistically significant differences in expression were observed for miR-10b (8,12), miR-21 (7,13,14), miR-93 (9,15), and miR-107 (10,16), enabling the differentiation between tumor and non-tumor control gastric tissue. miR-21 is the most frequently studied oncogenic miRNA in cancer, with overexpression repeatedly confirmed in gastric tumors (7,13,14).…”